WallStSmart

Andersen Group Inc. (ANDG)vsMEDIFAST INC (MED)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Andersen Group Inc. generates 117% more annual revenue ($838.69M vs $385.79M). ANDG leads profitability with a -0.3% profit margin vs -4.8%. MED earns a higher WallStSmart Score of 45/100 (D).

ANDG

Avoid

31

out of 100

Grade: F

Growth: 6.7Profit: 3.0Value: 5.0Quality: 7.5
Piotroski: 3/9Altman Z: 4.29

MED

Hold

45

out of 100

Grade: D

Growth: 2.0Profit: 2.0Value: 6.7Quality: 6.0
Piotroski: 2/9Altman Z: 5.46

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ANDG3 strengths · Avg: 9.3/10
Debt/EquityHealth
-96.2210/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.2910/10

Safe zone — low bankruptcy risk

Revenue GrowthGrowth
19.6%8/10

19.6% revenue growth

MED3 strengths · Avg: 9.3/10
Price/BookValuation
0.5x10/10

Reasonable price relative to book value

Altman Z-ScoreHealth
5.4610/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.978/10

Growing faster than its price suggests

Areas to Watch

ANDG4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-1.6%2/10

ROE of -1.6% — below average capital efficiency

Profit MarginProfitability
-0.3%1/10

Currently unprofitable

MED4 concerns · Avg: 2.5/10
Market CapQuality
$109.91M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-9.1%2/10

ROE of -9.1% — below average capital efficiency

Revenue GrowthGrowth
-36.9%2/10

Revenue declined 36.9%

Comparative Analysis Report

WallStSmart Research

Bull Case : ANDG

The strongest argument for ANDG centers on Debt/Equity, Altman Z-Score, Revenue Growth. Revenue growth of 19.6% demonstrates continued momentum.

Bull Case : MED

The strongest argument for MED centers on Price/Book, Altman Z-Score, PEG Ratio. PEG of 0.97 suggests the stock is reasonably priced for its growth.

Bear Case : ANDG

The primary concerns for ANDG are EPS Growth, Piotroski F-Score, Return on Equity.

Bear Case : MED

The primary concerns for MED are Market Cap, Piotroski F-Score, Return on Equity.

Key Dynamics to Monitor

ANDG profiles as a growth stock while MED is a turnaround play — different risk/reward profiles.

ANDG is growing revenue faster at 19.6% — sustainability is the question.

ANDG generates stronger free cash flow (77M), providing more financial flexibility.

Monitor PERSONAL SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MED scores higher overall (45/100 vs 31/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Andersen Group Inc.

CONSUMER CYCLICAL · PERSONAL SERVICES · USA

Andersen Group Inc. provides independent tax, valuation, and financial advisory services to individuals and family offices, businesses, and institutional clients in the United States.

MEDIFAST INC

CONSUMER CYCLICAL · PERSONAL SERVICES · USA

Medifast, Inc. manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutrition products in the United States and Asia-Pacific. The company is headquartered in Baltimore, Maryland.

Visit Website →

Want to dig deeper into these stocks?